Low-dose intracoronary alteplase unlikely to improve outcomes in STEMI patients treated with primary PCI
1. In this randomized controlled trial, low-dose intracoronary alteplase given early during primary percutaneous coronary intervention (PCI) for acute ST-Elevation ...